HRMY

Harmony Biosciences Holdings Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↓ 4/10
  • Value↑ 5/10
Harmony Biosciences Holdings sales and earnings growth
HRMY Growth
Neutral
  • Revenue Y/Y↑ 19.68%
  • EPS Y/Y↓ -5.24%
  • FCF Y/Y↑ 54.38%
Harmony Biosciences Holdings gross and profit margin trends
HRMY Profitability
Great
  • Gross margin ↑ 76.50%
  • EPS margin↑ 16.20%
  • ROIC 5Y↑ 49.79%
Harmony Biosciences Holdings net debt vs free cash flow
HRMY Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 15.1

Harmony Biosciences Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks